Europe Research Roundup: Johnson Matthey, Tomtom

Lotus Ventures

21/05/2015 07:45

May 21 (Reuters) - Securities analysts revised their ratings and price targets on several 
European companies, including Johnson Matthey and Tomtom, on Thursday.  
     
    HIGHLIGHTS 
    * Johnson Matthey Plc  JMAT.L : Jefferies starts with buy; price target 4,320p 
    * Tomtom  TOM2.AS : Morgan Stanley raises to overweight from equal-weight 
     
       
Following is a summary of research actions on European companies reported by Reuters on 
Thursday. Stock entries are in alphabetical order.    
     
 
    * Astrazeneca Plc  AZN.L : Jefferies cuts price target to 5,600p 
    * Bayer AG  BAYGn.DE : Jefferies cuts price target to 159 euros 
    * Eiffage  FOUG.PA : Barclays starts with underweight; price target 50 euros 
    * GKN Plc  GKN.L : Jefferies raises price target to 415p from 275p; rating buy 
    * Glaxosmithkline Plc  GSK.L : Jefferies cuts price target to 1,450p 
    * Groupe Eurotunnel  GETP.PA : Barclays starts with overweight; target 17 euros 
    * Johnson Matthey Plc  JMAT.L : Jefferies starts with buy 
    * Johnson Matthey Plc  JMAT.L : Jefferies starts with price target 4,320p 
    * Novartis AG  NOVN.VX : Jefferies cuts price target to Sfr 109 
    * Novo Nordisk A/S  NOVOb.CO : Jefferies cuts price target to Dkk 410 
    * Roche  ROG.VX : Jefferies raises price target to Sfr 340 
    * Sanofi SA  SASY.PA : Jefferies cuts price target to 100 euros 
    * Tomtom  TOM2.AS : Morgan Stanley raises to overweight from equal-weight 
    * Tomtom  TOM2.AS : Morgan Stanley revises target price to 12.20 euros from 5.60 euros 
    * Vinci  SGEF.PA : Barclays starts with equal weight; price target 56 euros  
 
 
 
 (Compiled by Rachel Chitra in Bengaluru) 
 ((rachel.chitra@thomsonreuters.com; within U.S. +1 646 223 8780; outside U.S. +91 80 67496149; 
Reuters Messaging: rachel.chitra.reuters.com@reuters.net)) 
 
Keywords: RESEARCH EUROPE/